Immunome, Inc.

14.94 USD
+0.02 (+0.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Immunome, Inc. stock is up 8.03% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 June’s closed higher than May. 100% of analysts rate it a buy.

About Immunome, Inc.

Immunome, Inc. discovers and develops antibody therapeutics for oncology and infectious disease. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.